99 related articles for article (PubMed ID: 6597236)
1. Phase I and early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies.
Takubo T; Tani Y; Kubota Y; Oguma S; Ueda T; Nakamura H; Shibata H; Masaoka T
Nihon Gan Chiryo Gakkai Shi; 1984 Feb; 19(1):1-7. PubMed ID: 6597236
[No Abstract] [Full Text] [Related]
2. [Early phase II study of PL-AC [N4-palmitoyl-(1-beta-D-arabinofuranosyl) cytosine] on hematopoietic malignancies].
Takubo T; Kubota Y; Tanaka T; Ueda T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):283-9. PubMed ID: 6576729
[TBL] [Abstract][Full Text] [Related]
3. [A phase II study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC].
Kimura K
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2475-81. PubMed ID: 3619459
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
5. [Cytosine-arabinoside in the treatment of acute leukemias].
Böhnel J; Gingold N; Hermansky F; Pawlowski M; Stacher A
Wien Med Wochenschr; 1972 Apr; 122(15):203-7. PubMed ID: 4527321
[No Abstract] [Full Text] [Related]
6. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
Masi M; Vivarelli F; Paolucci P; Vecchi V
Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
[No Abstract] [Full Text] [Related]
7. [Treatment of acute leukemia with newly synthesized N4-behenoyl-l-beta-D-arabinofuranosylcytosine (BH-AC) (author's transl)].
Sueyama H; Oguro M; Takagi T
Rinsho Ketsueki; 1981 Jul; 22(7):1109-15. PubMed ID: 7328768
[No Abstract] [Full Text] [Related]
8. Phase I--II study of N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
Kimura K; Yamada K; Uzuka Y; Maekawa T; Takaku F; Shimoyama M; Ogawa M; Amaki I; Osamura S; Ito M; Sakai Y; Oguro M; Hattori K; Hoshino A; Hirota Y; Ohta K; Nakamura T; Masaoka T; Kimura I; Ichimaru M
Recent Results Cancer Res; 1981; 76():232-40. PubMed ID: 7232852
[TBL] [Abstract][Full Text] [Related]
9. Phase III study of N4-behenoyl-l-beta-D-arabinofuranosylcytosine in adult acute leukemia-BH-AC-DMP therapy.
Yamada K; Suzuki H; Kato Y
Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1080-5. PubMed ID: 7331685
[No Abstract] [Full Text] [Related]
10. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
[TBL] [Abstract][Full Text] [Related]
11. [Patient with hypoplastic leukemia successfully treated with N4-palmitoyl-1-beta-D-arabinofuranosyl cytosine].
Uchida M; Tsutani H; Kagawa D; Ueda T; Domae N; Nakamura T
Nihon Naika Gakkai Zasshi; 1985 Dec; 74(12):1709-13. PubMed ID: 3831195
[No Abstract] [Full Text] [Related]
12. Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
Gaynon PS; Baum ES; Krivit W; Hammond D
Cancer Treat Rep; 1982 Jul; 66(7):1583-4. PubMed ID: 6284362
[No Abstract] [Full Text] [Related]
13. [Cytosine arabinoside in the therapy of acute leukoses].
Quaglino D; De Pasquale A; Curci G; Montero C; Piccinini L
Minerva Med; 1971 Jun; 62(45):2271-82. PubMed ID: 5281484
[No Abstract] [Full Text] [Related]
14. Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.
Finklestein JZ; Higgins G; Krivit W; Hammond D
Cancer Treat Rep; 1979 Aug; 63(8):1331-3. PubMed ID: 89907
[TBL] [Abstract][Full Text] [Related]
15. Our experience with cytosine arabinoside in the treatment of acute haemoblastoses.
Janele J; Rosa L
Neoplasma; 1973; 20(4):403-11. PubMed ID: 4517058
[No Abstract] [Full Text] [Related]
16. [Experience in the therapy of acute leukemia in the period from March, 1959 to February, 1971].
Quattrin N; Montuori R
Minerva Med; 1972 Mar; 63(24):1409-22. PubMed ID: 4502503
[No Abstract] [Full Text] [Related]
17. Approaches to the treatment of acute leukemia and lymphoma in adults.
Bodey GP; Rodriguez V
Semin Hematol; 1978 Jul; 15(3):221-61. PubMed ID: 353991
[No Abstract] [Full Text] [Related]
18. [Cytosine arabinoside in the polychemotherapy of acute leukemia].
Mandelli F
Minerva Med; 1972 Mar; 63(24):1436-44. PubMed ID: 4502506
[No Abstract] [Full Text] [Related]
19. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
[No Abstract] [Full Text] [Related]
20. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
